ABT R&D Expenses

Abbott Laboratories · R&D Expenses

ABT logo

ABT R&D Expenses

Latest reported$3.16B
ABT TTM R&D Expenses ($0.00 → $3.16B)
High-resolution chart · PNG

ABT r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Abbott Laboratories R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
3,158,000,000
3,008,000,000
2,955,000,000
2,948,000,000
2,876,000,000
2,841,000,000
2,821,000,000
2,783,000,000
2,731,000,000
2,744,000,000
2,715,000,000
2,716,000,000
2,835,000,000
2,809,000,000
2,852,000,000
2,919,000,000
2,811,000,000
2,781,000,000
2,738,000,000
2,678,000,000
2,586,000,000
2,496,000,000
2,418,000,000
2,295,000,000
2,309,000,000
2,322,000,000
2,416,000,000
2,402,000,000
2,381,000,000
2,377,000,000
2,288,000,000
2,345,000,000
2,265,000,000
2,212,000,000
2,172,000,000
1,892,000,000
1,735,000,000
1,563,000,000
1,401,000,000
1,432,000,000
1,474,000,000
1,471,000,000
1,405,000,000
1,397,000,000
1,326,000,000
1,316,000,000
1,390,000,000
1,415,000,000
1,465,000,000
1,493,000,000
1,452,000,000
2,207,431,000
3,014,431,000
3,662,431,000
4,322,431,000
4,332,607,000
4,178,607,000
4,205,607,000
4,129,607,000
4,273,632,000
4,342,632,000
4,162,632,000
3,962,632,000
3,414,048,000
3,011,048,000
2,823,048,000
2,743,791,000
2,728,374,000
2,732,734,000
2,719,597,000
2,688,811,000
2,619,581,000
2,579,939,000
2,506,550,000
2,464,967,000
2,398,733,000
2,375,640,000
2,841,503,000
2,748,271,000
2,642,496,000
2,473,740,000
1,869,661,000
1,821,175,000
1,794,750,000
1,737,579,000
1,728,831,000
1,721,199,000
1,742,925,000
1,790,226,000
1,756,469,000
1,733,472,000
1,680,273,000
1,634,399,000
1,611,138,000
1,561,792,000
1,590,663,000
1,598,104,000
1,615,953,000
1,577,552,000
1,465,869,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.